What Caught Our Attention in the Investment World? – Week of July 25-29, 2022
By Kuldip K. Ambastha On Wednesday, July 27, 2022, the stock of global pharmaceutical company Teva Pharmaceutical Industries Limited (TEVA) rose in price by +28.4% per share. Teva is the world’s largest generic medicine producer, and has been struggling for the last five years because of weakness in the American generic medicine sector plus intense …
Continue reading “What Caught Our Attention in the Investment World? – Week of July 25-29, 2022”